The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Sarcoidosis: Clinical Presentation, Immunopathogenesis, and Therapeutics
Abstract
Sarcoidosis is a multisystem granulomatous disorder that most often affects the lungs and may cause significant morbidity. Sarcoidosis can manifest as neurological disease, uveitis, blindness, end-stage pulmonary fibrosis, pulmonary hypertension, dysrhythmias, cardiomyopathy, hypercalcemia, and renal failure. Sarcoidosis persists as chronic disease in approximately one-third of those affected. Clinical pitfalls and misconceptions about the course of disease place this population at risk for delayed or inadequate care. While noncaseating granulomas are the histopathological hallmark of sarcoidosis, they also are nonspecific. No pathognomonic diagnostic test exists for sarcoidosis, so the diagnosis remains one of exclusion. While the etiology of sarcoidosis is still unknown, recent insights into its immunopathogenesis have moved investigators closer to finding more effective treatments. Corticosteroids remain the standard of care when treatment is indicated, despite their adverse effect profile. Clinical investigations of novel drugs and biological agents targeting mechanisms involving CD4 type 1 helper T cells may provide more effective, better tolerated therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
sarcoidosis, S. O. (1999) · American Journal of Respiratory and Critical Care Medicine · Cited by 1,953
Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis
BAUGHMAN, R. P., TEIRSTEIN, A. S., JUDSON, M. A., ROSSMAN, M. D., YEAGER, H., BRESNITZ, E. A., DePALO, L., HUNNINGHAKE, G., IANNUZZI, M. C., JOHNS, C. J., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2104046 · Cited by 1,808
Self-citationStatins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Conti, M., & Beavo, J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,183
Racial Differences in Sarcoidosis Incidence: A 5-Year Study in a Health Maintenance Organization
Rybicki, B. A., Major, M., Popovich, J., Maliank, M. J., & lannuzzi, M. C. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009096 · Cited by 1,011
Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Jain, M. K., & Ridker, P. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1901 · Cited by 915
A Case Control Etiologic Study of Sarcoidosis: Environmental and Occupational Risk Factors
Newman, L. S., Rose, C. S., Bresnitz, E. A., Rossman, M. D., Barnard, J., Frederick, M., Terrin, M. L., Weinberger, S. E., Moller, D. R., McLennan, G., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200402-249oc · Cited by 801
Self-citationDetection of Myocardial Damage in Patients With Sarcoidosis
Patel, M. R., Cawley, P. J., Heitner, J. F., Klem, I., Parker, M. A., Jaroudi, W. A., Meine, T. J., White, J. B., Elliott, M. D., Kim, H. W., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.851352 · Cited by 719
Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement
Baughman, R. P., Drent, M., Kavuru, M., Judson, M. A., Costabel, U., du Bois, R., Albera, C., Brutsche, M., Davis, G., Donohue, J. F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-402oc · Cited by 714
Sarcoidosis is associated with a truncating splice site mutation in BTNL2
Valentonyte, R., Hampe, J., Huse, K., Rosenstiel, P., Albrecht, M., Stenzel, A., Nagy, M., Gaede, K. I., Franke, A., Haesler, R., et al. (2005) · Nature Genetics · doi:10.1038/ng1519 · Cited by 491
Molecular action of methotrexate in inflammatory diseases.
Chan, E. S. L., & Cronstein, B. N. (2002) · Arthritis Research · doi:10.1186/ar419 · Cited by 463
Robinson, B. W., McLemore, T. L., & Crystal, R. G. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111852 · Cited by 458
Familial Aggregation of Sarcoidosis: A Case–Control Etiologic Study of Sarcoidosis (ACCESS)
RYBICKI, B. A., IANNUZZI, M. C., FREDERICK, M. M., THOMPSON, B. W., ROSSMAN, M. D., BRESNITZ, E. A., TERRIN, M. L., MOLLER, D. R., BARNARD, J., BAUGHMAN, R. P., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.11.2106001 · Cited by 452
Self-citationKinlay, S., Schwartz, G. G., Olsson, A. G., Rifai, N., Leslie, S. J., Sasiela, W. J., Szarek, M., Libby, P., & Ganz, P. (2003) · Circulation · doi:10.1161/01.cir.0000091404.09558.af · Cited by 405
Cardiac Involvement in Patients with Sarcoidosis
Mehta, D., Lubitz, S. A., Frankel, Z., Wisnivesky, J. P., Einstein, A. J., Goldman, M., Machac, J., & Teirstein, A. (2008) · Chest · doi:10.1378/chest.07-2784 · Cited by 398
Etanercept for the Treatment of Stage II and III Progressive Pulmonary Sarcoidosis
Utz, J. P., Limper, A. H., Kalra, S., Specks, U., Scott, J. P., Vuk-Pavlovic, Z., & Schroeder, D. R. (2003) · Chest · doi:10.1378/chest.124.1.177 · Cited by 390
Song, Z., Marzilli, L., Greenlee, B. M., Chen, E. S., Silver, R. F., Askin, F. B., Teirstein, A. S., Zhang, Y., Cotter, R. J., & Moller, D. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040429 · Cited by 372
Spontaneous Release of Interleukin-2 by Lung T Lymphocytes in Active Pulmonary Sarcoidosis
Pinkston, P., Bitterman, P. B., & Crystal, R. G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198304073081401 · Cited by 349
Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial.
Baughman, R. P., Winget, D., & Lower, E. E. (2000) · PubMed · Cited by 344
Ohira, H., Tsujino, I., Ishimaru, S., Oyama, N., Takei, T., Tsukamoto, E., Miura, M., Sakaue, S., Tamaki, N., & Nishimura, M. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0650-8 · Cited by 329
Teirstein, A. S., Machac, J., Almeida, O., Lu, P., Padilla, M. L., & Iannuzzi, M. C. (2007) · Chest · doi:10.1378/chest.07-1178 · Cited by 329
Self-citationPulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics: Table. 1—
Shorr, A. F., Helman, D. L., Davies, D. B., & Nathan, S. D. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00083404 · Cited by 290
Serum Amyloid A Regulates Granulomatous Inflammation in Sarcoidosis through Toll-like Receptor-2
Chen, E. S., Song, Z., Willett, M. H., Heine, S., Yung, R. C., Liu, M. C., Groshong, S. D., Zhang, Y., Tuder, R. M., & Moller, D. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0696oc · Cited by 243
The Diagnostic Pathway to Sarcoidosis*
Judson, M. A., Thompson, B. W., Rabin, D. L., Steimel, J., Knattereud, G. L., Lackland, D. T., Rose, C., Rand, C. S., Baughman, R. P., & Teirstein, A. S. (2003) · Chest · doi:10.1378/chest.123.2.406 · Cited by 223
The BTNL2 Gene and Sarcoidosis Susceptibility in African Americans and Whites
Rybicki, B. A., Walewski, J. L., Maliarik, M. J., Kian, H., & Iannuzzi, M. C. (2005) · The American Journal of Human Genetics · doi:10.1086/444435 · Cited by 222
Self-citationPentoxifylline in treatment of sarcoidosis.
Zabel, P., Entzian, P., Dalhoff, K., & Schlaak, M. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.5.9154873 · Cited by 220
Pharmacotherapy for pulmonary sarcoidosis: A delphi consensus study
Schutt, A. C., Bullington, W. M., & Judson, M. A. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2009.12.009 · Cited by 206
Pentoxifylline Inhibits TNF- α Production from Human Alveolar Macrophages
MARQUES, L. J., ZHENG, L., POULAKIS, N., GUZMAN, J., & COSTABEL, U. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.2.9804085 · Cited by 199
IL-12 and IL-18 Are Increased and Stimulate IFN-γ Production in Sarcoid Lungs
Shigehara, K., Shijubo, N., Ohmichi, M., Takahashi, R., Kon, S.-I., Okamura, H., Kurimoto, M., Hiraga, Y., Tatsuno, T., Abe, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.642 · Cited by 185
Moller, D. R. (1997) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70413-5 · Cited by 170
Bihan, H., Christozova, V., Dumas, J., Jomaa, R., Valeyre, D., Tazi, A., Reach, G., Krivitzky, A., & Cohen, R. (2007) · Medicine · doi:10.1097/md.0b013e31815585aa · Cited by 136
T cell contributions to the different phases of granuloma formation
Co, D. O., Hogan, L. H., Il-Kim, S., & Sándor, M. (2004) · Immunology Letters · doi:10.1016/j.imlet.2003.11.023 · Cited by 129
Treatment of Progressive Pulmonary Sarcoidosis with Cyclosporin A
Wyser, C. P., van Schalkwyk, E. M., Alheit, B., Bardin, P. G., & JOUBERT, J. R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.5.9506031 · Cited by 116
Genome-wide search for sarcoidosis susceptibility genes in African Americans
Iannuzzi, M. C., Iyengar, S. K., Gray‐McGuire, C., Elston, R. C., Baughman, R. P., Donohue, J. F., Hirst, K., Judson, M. A., Kavuru, M. S., MALIARIK, M. J., et al. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364235 · Cited by 109
Self-citationSteroid-sparing effects of pentoxifylline in pulmonary sarcoidosis.
Park, M. K., Fontana, Babaali, H., Gilbert-McClain, L. I., Stylianou, M. P., Joo, J., Moss, J., & Manganiello, V. (2009) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 96
Pulmonary and psychosocial findings at enrollment in the ACCESS study.
Yeager, H., Rossman, M. D., Baughman, R. P., Teirstein, A. S., Judson, M. A., Rabin, D. L., Iannuzzi, M. C., Rose, C. S., Bresnitz, E. A., DePalo, L., et al. (2005) · PubMed · Cited by 94
Self-citationT-lymphocytes and cytokines in sarcoidosis
Agostini, C., Meneghin, A., & Semenzato, G. (2002) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200209000-00016 · Cited by 83
Müller–Quernheim, J., Schürmann, M., Hofmann, S., Gaede, K. I., Fischer, A., Prasse, A., Zissel, G., & Schreiber, S. (2008) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.03.007 · Cited by 82
Giembycz, M. A. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-041sr · Cited by 68
Cited by
Valeyre, D., Prasse, A., Nunes, H., Uzunhan, Y., Brillet, P.-Y., & Müller-Quernheim, J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60680-7 · Cited by 1,087
Osborne, M. T., Hulten, E. A., Singh, A., Waller, A. H., Bittencourt, M. S., Stewart, G. C., Hainer, J., Murthy, V. L., Skali, H., Dorbala, S., et al. (2014) · Journal of Nuclear Cardiology · doi:10.1007/s12350-013-9828-6 · Cited by 298
Linke, M., Pham, H. T. T., Katholnig, K., Schnöller, T., Miller, A., Demel, F., Schütz, B., Rosner, M., Kovacic, B., Sukhbaatar, N., et al. (2017) · Nature Immunology · doi:10.1038/ni.3655 · Cited by 286
Sarcoidosis-associated fatigue
Drent, M., Lower, E. E., & De Vries, J. (2012) · European Respiratory Journal · doi:10.1183/09031936.00002512 · Cited by 285
An mTORC1‐Dependent Mouse Model for Cardiac Sarcoidosis
Bueno‐Beti, C., Lim, C. X., Protonotarios, A., Szabo, P. L., Westaby, J., Mazic, M., Sheppard, M. N., Behr, E., Hamza, O., Kiss, A., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030478 · Cited by 34
Metadata
- Authors
- Iannuzzi, M. C.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-01-26
- Volume
- 305
- Issue
- 4
- Pages
- 391
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1965053951
- Cited by
- 338
- References
- 39
- FWCI
- 20.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.